As Align Technology (ALGN) Valuation Rose, Shareholder Sanctuary Wealth Advisors Has Lowered Its Holding by $619,659; Quantitative Systematic Strategies Holds Stake in Boston Scientific (BSX)

May 25, 2018 - By Marie Mckinney

Align Technology, Inc. (NASDAQ:ALGN) Logo

Quantitative Systematic Strategies Llc increased its stake in Boston Scientific Corp (BSX) by 45.95% based on its latest 2017Q4 regulatory filing with the SEC. Quantitative Systematic Strategies Llc bought 31,390 shares as the company’s stock rose 7.69% while stock markets declined. The institutional investor held 99,704 shares of the medical and dental instruments company at the end of 2017Q4, valued at $2.47 million, up from 68,314 at the end of the previous reported quarter. Quantitative Systematic Strategies Llc who had been investing in Boston Scientific Corp for a number of months, seems to be bullish on the $41.82 billion market cap company. The stock decreased 0.28% or $0.08 during the last trading session, reaching $30.32. About 1.58M shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 9.97% since May 25, 2017 and is uptrending. It has underperformed by 1.58% the S&P500.

Sanctuary Wealth Advisors Llc decreased its stake in Align Technology Inc (ALGN) by 1.34% based on its latest 2017Q4 regulatory filing with the SEC. Sanctuary Wealth Advisors Llc sold 279 shares as the company’s stock rose 11.29% while stock markets declined. The institutional investor held 20,599 shares of the health care company at the end of 2017Q4, valued at $45.77M, down from 20,878 at the end of the previous reported quarter. Sanctuary Wealth Advisors Llc who had been investing in Align Technology Inc for a number of months, seems to be less bullish one the $25.57 billion market cap company. The stock increased 0.62% or $1.95 during the last trading session, reaching $318.99. About 979,748 shares traded or 1.84% up from the average. Align Technology, Inc. (NASDAQ:ALGN) has risen 117.77% since May 25, 2017 and is uptrending. It has outperformed by 106.22% the S&P500.

Another recent and important Boston Scientific Corporation (NYSE:BSX) news was published by Streetinsider.com which published an article titled: “JANA Shows New Stakes in Apple (AAPL), Boston Scientific (BSX), Dropbox (DBX), iQIYI (IQ) (more..) -13F” on May 15, 2018.

Investors sentiment increased to 1.34 in 2017 Q4. Its up 0.30, from 1.04 in 2017Q3. It increased, as 36 investors sold BSX shares while 158 reduced holdings. 86 funds opened positions while 174 raised stakes. 1.18 billion shares or 2.38% less from 1.21 billion shares in 2017Q3 were reported. Nomura has invested 0.01% in Boston Scientific Corporation (NYSE:BSX). Envestnet Asset Management holds 77,672 shares. Korea Investment reported 743,025 shares. Moreover, Edgestream Prtn LP has 0.34% invested in Boston Scientific Corporation (NYSE:BSX) for 11,481 shares. Cubist Systematic Strategies Ltd Liability Company stated it has 0.67% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Mutual Of America Capital Management Llc invested in 217,122 shares or 0.08% of the stock. Renaissance Technologies Ltd Company reported 1.15M shares or 0.03% of all its holdings. Teacher Retirement Of Texas has invested 0.06% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Guggenheim holds 0.14% or 2.32 million shares. Tci Wealth Advsrs Incorporated invested in 0.02% or 2,257 shares. Texas Permanent School Fund holds 0.12% or 374,868 shares in its portfolio. Ameritas Prns Incorporated stated it has 30,285 shares or 0.03% of all its holdings. Adage Cap Ltd Liability Corp owns 5.21 million shares. Art Limited Co holds 0.04% or 32,800 shares in its portfolio. Cap Rech Invsts holds 0.08% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 10.58M shares.

Quantitative Systematic Strategies Llc, which manages about $315.26M and $394.18 million US Long portfolio, decreased its stake in Physicians Realty Trust (NYSE:DOC) by 88,080 shares to 36,646 shares, valued at $659,000 in 2017Q4, according to the filing. It also reduced its holding in Gallagher Arthur J & Co (NYSE:AJG) by 12,375 shares in the quarter, leaving it with 33,579 shares, and cut its stake in Henry Schein Inc (NASDAQ:HSIC).

Among 32 analysts covering Boston Scientific Corporation (NYSE:BSX), 26 have Buy rating, 0 Sell and 6 Hold. Therefore 81% are positive. Boston Scientific Corporation had 99 analyst reports since July 27, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Hold” on Friday, October 6. The company was initiated on Thursday, November 12 by Citigroup. BMO Capital Markets maintained Boston Scientific Corporation (NYSE:BSX) on Friday, October 27 with “Outperform” rating. Barclays Capital maintained Boston Scientific Corporation (NYSE:BSX) rating on Wednesday, June 28. Barclays Capital has “Buy” rating and $3100 target. RBC Capital Markets maintained the shares of BSX in report on Thursday, April 28 with “Outperform” rating. FinnCap maintained Boston Scientific Corporation (NYSE:BSX) on Thursday, October 29 with “Corporate” rating. The firm has “Overweight” rating given on Monday, March 19 by Morgan Stanley. RBC Capital Markets maintained Boston Scientific Corporation (NYSE:BSX) on Tuesday, May 30 with “Buy” rating. The stock has “Neutral” rating by BTIG Research on Monday, May 23. The firm earned “Buy” rating on Wednesday, October 11 by BMO Capital Markets.

Since December 29, 2017, it had 0 insider purchases, and 18 insider sales for $9.29 million activity. Pierce David A had sold 3,800 shares worth $102,600 on Monday, March 5. $603,368 worth of stock was sold by Thepaut Eric Francis Yves on Thursday, May 17. 15,835 shares valued at $399,865 were sold by Phalen Michael P. on Friday, December 29. $1.21M worth of Boston Scientific Corporation (NYSE:BSX) shares were sold by Ballinger Kevin J.. $225,413 worth of Boston Scientific Corporation (NYSE:BSX) shares were sold by Butcher Arthur C. Brennan Daniel J. sold $1.68M worth of stock or 60,209 shares.

Since February 2, 2018, it had 1 insider purchase, and 8 selling transactions for $52.33 million activity. Olson Jennifer sold $1.07 million worth of Align Technology, Inc. (NASDAQ:ALGN) on Monday, May 7. Another trade for 15,000 shares valued at $3.97 million was made by LARKIN C RAYMOND JR on Monday, May 7. $5.79 million worth of Align Technology, Inc. (NASDAQ:ALGN) was sold by LACOB JOSEPH. HOGAN JOSEPH M also bought $350,445 worth of Align Technology, Inc. (NASDAQ:ALGN) on Tuesday, February 13. Another trade for 82,000 shares valued at $20.73 million was made by PRESCOTT THOMAS M on Monday, April 30. $11.91M worth of Align Technology, Inc. (NASDAQ:ALGN) was sold by Wright Emory on Friday, February 2.

More notable recent Align Technology, Inc. (NASDAQ:ALGN) news were published by: Streetinsider.com which released: “UPDATE: Align Technology (ALGN) PT Raised to Street High $350 at Stifel” on May 22, 2018, also Nasdaq.com with their article: “Align Technology Opens Invisalign® Treatment Planning and Training Facility in Germany” published on May 04, 2018, Seekingalpha.com published: “Key events next week – healthcare” on May 18, 2018. More interesting news about Align Technology, Inc. (NASDAQ:ALGN) were released by: Benzinga.com and their article: “8 Biggest Price Target Changes For Thursday” published on May 24, 2018 as well as Seekingalpha.com‘s news article titled: “Market Values Stocks Incorrectly In The Short Term – Cramer’s Mad Money (5/24/18)” with publication date: May 25, 2018.

Among 17 analysts covering Align Technology (NASDAQ:ALGN), 14 have Buy rating, 0 Sell and 3 Hold. Therefore 82% are positive. Align Technology had 68 analyst reports since July 27, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the shares of ALGN in report on Friday, January 29 with “Buy” rating. Leerink Swann maintained it with “Outperform” rating and $360 target in Thursday, May 24 report. The stock has “Buy” rating by Morgan Stanley on Monday, June 19. As per Wednesday, November 18, the company rating was initiated by Piper Jaffray. Barclays Capital maintained the stock with “Overweight” rating in Thursday, April 26 report. As per Friday, October 23, the company rating was maintained by Stifel Nicolaus. The firm has “Hold” rating given on Friday, January 19 by Stephens. Robert W. Baird maintained the stock with “Buy” rating in Friday, October 27 report. The company was maintained on Thursday, November 9 by Credit Suisse. The company was maintained on Friday, July 28 by Roth Capital.

Investors sentiment is 0.93 in 2017 Q4. Its the same as in 2017Q3. It is flat, as 37 investors sold ALGN shares while 216 reduced holdings. only 100 funds opened positions while 136 raised stakes. 60.90 million shares or 3.22% less from 62.92 million shares in 2017Q3 were reported. Trexquant Invest LP reported 9,393 shares stake. Aviva Plc owns 0.06% invested in Align Technology, Inc. (NASDAQ:ALGN) for 44,160 shares. Autus Asset Mngmt Limited reported 15,333 shares. Ngam Advsr Ltd Partnership has 13,269 shares. Asset Management reported 4,848 shares stake. Ing Groep Nv invested 0.04% in Align Technology, Inc. (NASDAQ:ALGN). Ubs Asset Mngmt Americas holds 0.04% or 225,662 shares. 1832 Asset Limited Partnership invested in 0.18% or 258,400 shares. Sandy Spring Bancorporation has invested 0% of its portfolio in Align Technology, Inc. (NASDAQ:ALGN). Hanseatic Mgmt Svcs stated it has 8,858 shares or 1.98% of all its holdings. Caprock Grp Inc reported 1,834 shares. Matarin Capital Management Ltd has invested 0.21% in Align Technology, Inc. (NASDAQ:ALGN). Conning holds 0.01% of its portfolio in Align Technology, Inc. (NASDAQ:ALGN) for 1,140 shares. Moreover, Ahl Prns Llp has 0.05% invested in Align Technology, Inc. (NASDAQ:ALGN) for 13,341 shares. Moreover, Ipswich Investment Management has 0.1% invested in Align Technology, Inc. (NASDAQ:ALGN) for 1,015 shares.

Boston Scientific Corporation (NYSE:BSX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts